reference/13446185

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13446185

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	643
issn	0920-1211
issueIdentifier	4
pageRange	634-643
publicationName	Epilepsy Research
startingPage	634
bibliographicCitation	Zellinger C, Salvamoser JD, Soerensen J, van Vliet EA, Aronica E, Gorter J, Potschka H. Pre-treatment with the NMDA receptor glycine-binding site antagonist L-701,324 improves pharmacosensitivity in a mouse kindling model. Epilepsy Res. 2014 May;108(4):634–43. doi: 10.1016/j.eplepsyres.2014.02.012. PMID: 24656981.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2a78fc8832373c0c9f044c661a79bcac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a6684b830bed73261646e01ca2dab523 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fa1c64eb998e3571c17496ca3bee5009 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1506-0252 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8493ad2d492383bfaa1609cdc99da7e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7510fcec7b9743a996f72ac37236c9fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ebe9eff518572bfbaa210b16ece2abcd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21828ca1a13733c8e6505aa973fb871e
date	201405
identifier	https://pubmed.ncbi.nlm.nih.gov/24656981 https://doi.org/10.1016/j.eplepsyres.2014.02.012
isPartOf	https://portal.issn.org/resource/ISSN/0920-1211 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Pre-treatment with the NMDA receptor glycine-binding site antagonist L-701,324 improves pharmacosensitivity in a mouse kindling model
discusses	http://id.nlm.nih.gov/mesh/M0016514 http://id.nlm.nih.gov/mesh/M0023650 http://id.nlm.nih.gov/mesh/M0249335 http://id.nlm.nih.gov/mesh/M0001382 http://id.nlm.nih.gov/mesh/M0028006 http://id.nlm.nih.gov/mesh/M0029890
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000927Q000627 http://id.nlm.nih.gov/mesh/D015363Q000494 http://id.nlm.nih.gov/mesh/D012640Q000188 http://id.nlm.nih.gov/mesh/D010634Q000627 http://id.nlm.nih.gov/mesh/D007696Q000187 http://id.nlm.nih.gov/mesh/D018691Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001522Q000187 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D001921Q000378 http://id.nlm.nih.gov/mesh/D004195 http://id.nlm.nih.gov/mesh/D001921Q000187 http://id.nlm.nih.gov/mesh/D020168Q000378 http://id.nlm.nih.gov/mesh/D004347 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D012640Q000378
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54682505 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_2b41adbd094947475b63355088c8b2f4 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4763 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7203

Total number of triples: 55.